155 related articles for article (PubMed ID: 36658172)
1. Age-specific trend and birth cohort effect on different histologic types of uterine corpus cancers.
Tai YJ; Chiang CJ; Chiang YC; Wu CY; Lee WC; Cheng WF
Sci Rep; 2023 Jan; 13(1):1019. PubMed ID: 36658172
[TBL] [Abstract][Full Text] [Related]
2. Racial and Ethnic Differences in Hysterectomy-Corrected Uterine Corpus Cancer Mortality by Stage and Histologic Subtype.
Clarke MA; Devesa SS; Hammer A; Wentzensen N
JAMA Oncol; 2022 Jun; 8(6):895-903. PubMed ID: 35511145
[TBL] [Abstract][Full Text] [Related]
3. Hysterectomy-Corrected Uterine Corpus Cancer Incidence Trends and Differences in Relative Survival Reveal Racial Disparities and Rising Rates of Nonendometrioid Cancers.
Clarke MA; Devesa SS; Harvey SV; Wentzensen N
J Clin Oncol; 2019 Aug; 37(22):1895-1908. PubMed ID: 31116674
[TBL] [Abstract][Full Text] [Related]
4. Endometrial cancer risk and trends among distinct African descent populations.
Medina HN; Penedo FJ; Joachim C; Deloumeaux J; Koru-Sengul T; Macni J; Bhakkan B; Peruvien J; Schlumbrecht MP; Pinheiro PS
Cancer; 2023 Sep; 129(17):2717-2726. PubMed ID: 37357566
[TBL] [Abstract][Full Text] [Related]
5. Nationwide surveillance in uterine cancer: survival analysis and the importance of birth cohort: 30-year population-based registry in Taiwan.
Huang CY; Chen CA; Chen YL; Chiang CJ; Hsu TH; Lin MC; Lai MS; Chen CJ; You SL; Cheng WF
PLoS One; 2012; 7(12):e51372. PubMed ID: 23251510
[TBL] [Abstract][Full Text] [Related]
6. Trends in hysterectomy-corrected uterine cancer mortality rates during 2002 to 2015: mortality of nonendometrioid cancer on the rise?
Gustafson LW; Booth BB; Kahlert J; Ørtoft G; Mejlgaard E; Clarke MA; Wentzensen N; Rositch AF; Hammer A
Int J Cancer; 2021 Feb; 148(3):584-592. PubMed ID: 32683690
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous presentation of carcinoma involving the ovary and the uterine corpus.
Eifel P; Hendrickson M; Ross J; Ballon S; Martinez A; Kempson R
Cancer; 1982 Jul; 50(1):163-70. PubMed ID: 7083121
[TBL] [Abstract][Full Text] [Related]
8. Population-based analysis of pathologic data: a new approach to the investigation of uterine endometrial and ovarian endometrioid carcinomas.
Henson DE; Schwartz AM; Tilara A; Grimley PM; Anderson WF
Arch Pathol Lab Med; 2007 Sep; 131(9):1337-42. PubMed ID: 17824787
[TBL] [Abstract][Full Text] [Related]
9. Outcome of uterine clear cell carcinomas compared to endometrioid carcinomas and poorly-differentiated endometrioid carcinomas.
Petignat P; Usel M; Gauthier P; Popowski Y; Pelte MF; Bouchardy C; Verkooijen HM
Eur J Gynaecol Oncol; 2008; 29(1):57-60. PubMed ID: 18386465
[TBL] [Abstract][Full Text] [Related]
10. Histopathologic subtyping of cervical adenocarcinoma reveals increasing incidence rates of endometrioid tumors in all age groups: a population based study with review of all nonsquamous cervical carcinomas in Norway from 1966 to 1970, 1976 to 1980, and 1986 to 1990.
Alfsen GC; Thoresen SO; Kristensen GB; Skovlund E; Abeler VM
Cancer; 2000 Sep; 89(6):1291-9. PubMed ID: 11002225
[TBL] [Abstract][Full Text] [Related]
11. Use and outcomes of minimally invasive hysterectomy for women with nonendometrioid endometrial cancers.
Nieto VL; Huang Y; Hou JY; Tergas AI; St Clair CM; Ananth CV; Neugut AI; Hershman DL; Wright JD
Am J Obstet Gynecol; 2018 Nov; 219(5):463.e1-463.e12. PubMed ID: 30086293
[TBL] [Abstract][Full Text] [Related]
12. Uterine carcinosarcomas and grade 3 endometrioid cancers: evidence for distinct tumor behavior.
Bansal N; Herzog TJ; Seshan VE; Schiff PB; Burke WM; Cohen CJ; Wright JD
Obstet Gynecol; 2008 Jul; 112(1):64-70. PubMed ID: 18591309
[TBL] [Abstract][Full Text] [Related]
13. Trends in incidence of and mortality from uterine and ovarian cancer in Mid and South Limburg, The Netherlands, 1986-2003.
Kellert IM; Botterweck AA; Huveneers JA; Dirx MJ
Eur J Cancer Prev; 2009 Feb; 18(1):85-9. PubMed ID: 19077569
[TBL] [Abstract][Full Text] [Related]
14. Cancer of the corpus uteri in white and black women in Michigan, 1985-1994: an analysis of trends in incidence and mortality and their relation to histologic subtype and stage.
Madison T; Schottenfeld D; Baker V
Cancer; 1998 Oct; 83(8):1546-54. PubMed ID: 9781948
[TBL] [Abstract][Full Text] [Related]
15. Improved long-term survival of corpus cancer in Japan: A 40-year population-based analysis.
Yagi A; Ueda Y; Ikeda S; Miyoshi A; Nakagawa S; Hiramatsu K; Kobayashi E; Kimura T; Ito Y; Nakayama T; Nakata K; Morishima T; Miyashiro I; Kimura T
Int J Cancer; 2022 Jan; 150(2):232-242. PubMed ID: 34494658
[TBL] [Abstract][Full Text] [Related]
16. Racial disparities in high-risk uterine cancer histologic subtypes: A United States Cancer Statistics study.
Abel MK; Liao CI; Chan C; Lee D; Rohatgi A; Darcy KM; Tian C; Mann AK; Maxwell GL; Kapp DS; Chan JK
Gynecol Oncol; 2021 May; 161(2):470-476. PubMed ID: 33722415
[TBL] [Abstract][Full Text] [Related]
17. Extent of lymph node dissection and overall survival in patients with uterine carcinosarcoma, papillary serous and endometrioid adenocarcinoma: A retrospective cohort study.
Alagkiozidis I; Weedon J; Grossman A; Wang P; Mize B; Wilson K; Shah T; Economos K; Salame G; Abulafia O; Lee YC
Int J Surg; 2015 Dec; 24(Pt A):9-13. PubMed ID: 26476418
[TBL] [Abstract][Full Text] [Related]
18. Incidence of endometrioid and clear-cell ovarian cancer in histological proven endometriosis: the ENOCA population-based cohort study.
Hermens M; van Altena AM; Nieboer TE; Schoot BC; van Vliet HAAM; Siebers AG; Bekkers RLM
Am J Obstet Gynecol; 2020 Jul; 223(1):107.e1-107.e11. PubMed ID: 31981507
[TBL] [Abstract][Full Text] [Related]
19. Endometrioid carcinomas of the uterine corpus with sex cord-like formations, hyalinization, and other unusual morphologic features: a report of 31 cases of a neoplasm that may be confused with carcinosarcoma and other uterine neoplasms.
Murray SK; Clement PB; Young RH
Am J Surg Pathol; 2005 Feb; 29(2):157-66. PubMed ID: 15644772
[TBL] [Abstract][Full Text] [Related]
20. Incidence and survival trends of uncommon corpus uteri malignancies in the Netherlands, 1989-2008.
Boll D; Verhoeven RH; van der Aa MA; Pauwels P; Karim-Kos HE; Coebergh JW; van Doorn HC
Int J Gynecol Cancer; 2012 May; 22(4):599-606. PubMed ID: 22398706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
